Почетна › Мијелофиброза › Њујорк › New York City
Kliničke studije za Мијелофиброза u gradu New York City, NY
Jedna studija za Мијелофиброза traži učesnike na lokaciji u gradu New York City ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Тражи се учесникФаза 3
- Columbia University Medical Center New York Presbyterian, New York
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Тражи се учесникФаза 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Тражи се учесникФаза 2
- GSK Investigational Site, New York
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Тражи се учесникФаза 2
- NYP/Weill Cornell Medical Center, New York
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
Тражи се учесникФаза 1
- Site US01, New York
- Site US02, New York
Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
Тражи се учесникФаза 2
- Icahn School of Medicine at Mount Sinai, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Тражи се учесникФаза 1
- Columbia University, New York
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Тражи се учесникФаза 1/2
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Тражи се учесникФаза 1
- Icahn School of Medicine At Mount Sinai, New York
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Тражи се учесникФаза 2
- Ruttenberg Treatment Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center, New York
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Тражи се учесникФаза 1
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Тражи се учесникФаза 2
- Memorial Sloan Kettering, New York
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Тражи се учесникФаза 2
- Weill Cornell Medicine NewYork-Presbyterian, New York
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center, New York
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Тражи се учесникФаза 2
- Ruttenberg Treatment Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, New York
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Тражи се учесникФаза 3
- ICAHN School of Medicine at Mount Sinai, New York
Studije za Мијелофиброза u drugim gradovima
- Houston, TX20 студија
- Boston, MA13 студија
- Durham, NC13 студија
- Columbus, OH12 студија
- Seattle, WA12 студија
- Tampa, FL11 студија
- Nashville, TN11 студија
- Miami, FL11 студија
- Salt Lake City, UT11 студија
- Ann Arbor, MI10 студија
- Atlanta, GA10 студија
- Baldwin Park, CA10 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.